(PPD) Community Analysis from
Bulls REASONS TO BUY
|
100%
agree
17 votes
|
Cash flow from operations grew at a faster rate than net income |
|
100%
agree
3 votes
|
Exclusive association with the Blastoff Network (viral marketing company) |
Bears REASONS TO SELL
May 23, 2013
(Stock Blog Hub,
10/11/11)
Pharmaceutical drug research company Pharmaceutical Product Development, Inc. (PPDI) recently announced that it has entered into an agreement to be acquired by privately...(read more)
(Stock Wizard,
7/18/11)
Shares of Pharmaceutical Product Development Inc. (NASDAQ: PPDI) jumped more than 16% on Monday after the Wall Street Journal reporte that the company is exploring a potential sale, citing...(read more)
(Penny Stock DD,
4/26/11)
Contract drug developer Pharmaceutical Product Development Inc. said Tuesday that its first-quarter net income surged on a boost in revenue from clinical development services.
PPD earned $37.6...(read more)
Pre-Paid Legal Services (PPD) Company Overview
There is no analysis for PPD yet. But you can go to Wikinvest to help create one!
Advertisement
Advertisement